300519 Share Price | Zhejiang Xinguang Pharmaceutical Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of -3.15% and Operating profit at -12.43% over the last 5 years

Positive results in Mar 26

With ROE of 6.48%, it has a expensive valuation with a 1.50 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 1,400 Million (Small Cap)

P/E

34.00

Industry P/E

Dividend Yield

3.43%

Debt Equity

-0.89

Return on Equity

6.48%

Price to Book

1.62

Revenue and Profits:

Net Sales:

88 Million

(Quarterly Results - Mar 2026)

Net Profit:

26 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.33%

6 Months

-12.91%

1 Year

-18.89%

2 Years

16.34%

3 Years

-7.87%

4 Years

-10.77%

5 Years

-22.91%

Zhejiang Xinguang Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-3.15%

EBIT Growth (5y)

-12.43%

EBIT to Interest (avg)

65.85

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.85

Sales to Capital Employed (avg)

0.32

Tax Ratio

14.76%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

56.14%

ROE (avg)

9.91%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.21

EV to EBIT

20.49

EV to EBITDA

17.12

EV to Capital Employed

12.24

EV to Sales

4.36

PEG Ratio

4.50

Dividend Yield

2.51%

ROCE (Latest)

59.74%

ROE (Latest)

6.48%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -5.14% vs -7.16% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 7.76% vs 7.46% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88.50",
          "val2": "93.30",
          "chgp": "-5.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.00",
          "val2": "22.00",
          "chgp": "27.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.40",
          "val2": "24.50",
          "chgp": "7.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "316.10%",
          "val2": "195.00%",
          "chgp": "12.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88.50",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.00",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.40",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "316.10%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

88.50

93.30

-5.14%

Operating Profit (PBDIT) excl Other Income

28.00

22.00

27.27%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

26.40

24.50

7.76%

Operating Profit Margin (Excl OI)

316.10%

195.00%

12.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -5.14% vs -7.16% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 7.76% vs 7.46% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Change(%)

Net Sales

88.50

0.00

Operating Profit (PBDIT) excl Other Income

28.00

0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

26.40

0.00

Operating Profit Margin (Excl OI)

316.10%

0.00%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available